 Connection
Samantha Stonbraker to Anti-HIV Agents
This is a "connection" page, showing publications Samantha Stonbraker has written about Anti-HIV Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.654 |
|
|
|
-
Stonbraker S, Befus M, Nadal LL, Halpern M, Larson E. Evaluating the utility of provider-recorded clinical status in the medical records of HIV-positive adults in a limited-resource setting. Int J STD AIDS. 2017 06; 28(7):685-692.
Score: 0.303
-
Rael CT, Das D, Porter J, Lopez-Ríos J, Abascal E, Dolezal C, Vaughn MP, Giffenig P, Lopez JM, Stonbraker S, Sun C, Velasco RA, Bitterfeld L, Bockting WO, Bauermeister J. Provider Factors Likely to Impact Access and Uptake of Long-Acting Injectable Cabotegravir for Transgender Women in the United States: Results of a Qualitative Study. J Assoc Nurses AIDS Care. 2024 Sep-Oct 01; 35(5):437-449.
Score: 0.132
-
Bracho-Sanchez E, Stonbraker S, Halpern M, Wood S, Lowenthal E. HIV pre-exposure prophylaxis: assessment of acceptability among members of HIV serodiscordant/serostatus unknown couples. Int J STD AIDS. 2022 06; 33(7):687-693.
Score: 0.113
-
Bast ES, Stonbraker S, Halpern M, Lowenthal E, Gross R. Barriers to HIV treatment adherence among adults living with HIV in the eastern Dominican Republic. Int J STD AIDS. 2021 10; 32(11):1014-1019.
Score: 0.106
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|